Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa (Q71142872)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8662679%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

title

Modulation of contact system proteases by glycosaminoglycans. Selective enhancement of the inhibition of factor XIa (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8662679%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

author name string

W A Wuillemin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8662679%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

E Eldering

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8662679%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

F Citarella

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8662679%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

C P de Ruig

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8662679%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

H ten Cate

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8662679%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

C E Hack

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8662679%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

language of work or name

English

0 references

publication date

1 May 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8662679%20AND%20SRC:MED&resulttype=core&format=json

Journal of Biological Chemistry

16 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8662679%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

volume

271

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8662679%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

issue

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8662679%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

page(s)

12913-12918

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8662679%20AND%20SRC:MED&resulttype=core&format=json

Factor XI: a review of its biochemistry and deficiency

16 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

The coagulation cascade: initiation, maintenance, and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Surface-mediated defense reactions. The plasma contact activation system

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor)

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

A rapid enzyme-linked immunosorbent assay for human factor XI

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Inhibition of factor XIa by antithrombin III

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Anticoagulant Action of Heparin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Inhibitory spectrum of alpha 2-plasmin inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Proteoglycans: structures and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Proteoglycans in health and disease: structures and functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Role of heparan sulfate in immune system-blood vessel interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Effect of negatively charged activating compounds on inactivation of factor XIIa by Cl inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Inhibition of human blood coagulation factor XIa by C-1 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Glycosaminoglycans and the regulation of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Kinetics of reaction of human C-inhibitor with the human complement system proteases Cr and Cs

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

The molecular-mass dependence of dextran sulfate enhancement of inactivation of thrombin and fibrinogen and on factor Xa neutralization by antithrombin III

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

More to "heparin" than anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Heparin binding site, conformational change, and activation of antithrombin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Action of heparin on the inhibition of thrombin by alpha 1-proteinase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Contribution of Plasma Protease Inhibitors to the Inactivation of Kallikrein in Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Major inhibitors of the contact phase coagulation factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.271.22.12913

21 January 2018

Identifiers

DOI

10.1074/JBC.271.22.12913

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8662679%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference